sk treatment resulted in haemorrhage requiring treatment in 0.5 % as compared with 0.2 % in the placebo group , more cases of proved cerebral haemorrhage , 0.1 % as compared with 0.0 % , but fewer cases of cerebral apoplexy , 0.7 % as compared with 0.8 % .
C0038418
sk
C0019080
haemorrhage